Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
19.08
-0.12 (-0.63%)
Sep 30, 2025, 3:00 PM CST
SHA:600161 Market Cap
SHA:600161 has a market cap or net worth of 37.73 billion as of October 3, 2025. Its market cap has decreased by -20.23% in one year.
Market Cap
37.73B
Enterprise Value
39.35B
Revenue
6.30B
Ranking
n/a
PE Ratio
26.13
Stock Price
19.08
Market Cap Chart
Since March 8, 2000, SHA:600161's market cap has increased from 3.95B to 37.73B, an increase of 855.74%. That is a compound annual growth rate of 9.23%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 30, 2025 | 37.73B | -6.93% |
Dec 31, 2024 | 40.54B | -20.49% |
Dec 29, 2023 | 50.98B | 30.38% |
Dec 30, 2022 | 39.10B | -1.67% |
Dec 31, 2021 | 39.77B | -23.98% |
Dec 31, 2020 | 52.31B | 79.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 476.78B |
WuXi AppTec | 328.32B |
Shenzhen Mindray Bio-Medical Electronics | 297.14B |
Sichuan Biokin Pharmaceutical | 150.50B |
Shanghai United Imaging Healthcare | 124.40B |
Zhangzhou Pientzehuang Pharmaceutical., | 118.73B |
Aier Eye Hospital Group | 114.71B |
Yunnan Baiyao Group Co.,Ltd | 101.26B |